Federal Register / Vol. 74, No. 150 / Thursday, August 6, 2009 / Notices 39333 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Regulaton of 

Placental Signaling and Function by 

Maternal Nutrient Restriction. 

Date: August 12, 2009. 

Time: 11 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Room 5B01, Rockville, 

MD 20852 (Telephone Conference Call). 

Contact Person: Peter Zelazowski, PhD, 

Scientific Review Officer, Division of 

Scientific Review, Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development, NIH, 6100 Executive 

Boulevard, Rm. 5B01, Bethesda, MD 20892– 

7510. 301–435–6902. 

peter.zelazowski@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel. Initiation of Human 

Labor: Prevention of Prematurity. 

Date: August 14, 2009. 

Time: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Room 5B01, Bethesda, 

MD (Telephone Conference Call). 

Contact Person: Peter Zelazowski, PhD, 

Scientific Review Officer, Division of 

Scientific Review, Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development, NIH, 6100 Executive 

Boulevard, Rm. 5B01, Bethesda, MD 20892– 

7510. 301–435–6902. 

peter.zelazowski@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: July 30, 2009. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–18870 Filed 8–5–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Capacity 

Building Assistance (CBA) To Improve 

the Delivery and Effectiveness of 

Human Immunodeficiency Virus (HIV) 

Prevention Services for High-Risk and/ 

or Racial/Ethnicity Minority 

Populations, Program Announcement 

Number PS09–906, Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting. 

Time and Date: 8:30 a.m.–5:30 p.m., 

August 21, 2009 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include an initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Capacity Building Assistance 

(CBA) to Improve the Delivery and 

Effectiveness of Human Immunodeficiency 

Virus (HIV) Prevention Services for HighRisk and/or Racial/Ethnicity Minority 

Populations, PS09–906.’’ The meeting was 

initially convened June 15–18, 2009. A 

reviewer conflict of interest was confirmed 

by CDC staff during a pre-decisional site 

visit. The panel will be reconvened to review 

the four affected applications. 

For More Information Contact: Monica 

Farmer, M.Ed., Public Health Analyst, 

Strategic Science and Program Unit, Office of 

the Director, Coordinating Center for 

Infectious Diseases, CDC, 1600 Clifton Road, 

NE., Mailstop E–60, Atlanta, GA 30333, 

Telephone: (404) 498–2277. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: July 31, 2009. 

Andre Tyler, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E9–18808 Filed 8–5–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SPORE in 

Breast, Leukemia, Prostate and Skin Cancers. 

Date: September 9–10, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, Montgomery County 

Conference Center Facility, 5701 Marinelli 

Road, North Bethesda, MD 20852. 

Contact Person: Caron A. Lyman, PhD, 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, 6116 

Executive Blvd, Room 8119, Bethesda, MD 

20892–8328, 301–451–4761, 

lymanc@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SPORE in 

GI, HN, Lung, and Pancreatic Cancers. 

Date: September 9–10, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, Montgomery County 

Conference Center Facility, 5701 Marinelli 

Road, North Bethesda, MD 20852. 

Contact Person: Shamala K. Srinivas, PhD, 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, 6116 

Executive Boulevard, Room 8123, Bethesda, 

MD 20892, 301–594–1224, ss537t@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 


jlentini on DSKJ8SOYB1PROD with NOTICES